Malarone and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Malarone (atovaquone; proguanil hydrochloride) and Profen (ibuprofen). Common drug interactions include bone marrow failure among females and erythema multiforme among males.

The phase IV clinical study analyzes what interactions people have when they take Malarone and Profen. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Malarone?

Malarone has active ingredients of atovaquone; proguanil hydrochloride. It is often used in malaria. eHealthMe is studying from 3,098 Malarone users. Check the latest studies of Malarone.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,312 Profen users. Check the latest studies of Profen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

18 people who take Malarone and Profen together, and have interactions are studied.

Malarone and Profen drug interactions.

What are the common drug interactions of Malarone and Profen, by gender? *:

female:

  1. Bone marrow failure
  2. Chemical burn of skin
  3. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  4. Drug hypersensitivity
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Dyspnoea (difficult or laboured respiration)
  7. Escherichia infection (bacterial infection by escherichia coli)
  8. Face oedema (swelling of face)
  9. Hepatocellular damage (liver damage)
  10. Hypersomnia (excessive daytime sleepiness (eds))

male:

  1. Erythema multiforme (a type of hypersensitivity reaction)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Oedema peripheral (superficial swelling)
  4. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  5. Vision blurred

What are the common drug interactions of Malarone and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abnormal dreams
  2. Angioedema (rapid swelling of the dermis)
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Hypersomnia (excessive daytime sleepiness (eds))
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Pulmonary infarction (death of a small area of lung)
  7. Respiration (transport of oxygen from the outside air to the cells within tissues)
  8. Swelling face
  9. Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Upper-airway cough syndrome

40-49:

n/a

50-59:

  1. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  2. Face oedema (swelling of face)
  3. Hepatocellular damage (liver damage)
  4. Inflammation
  5. Leukocytosis (increased white blood cells)
  6. Photosensitivity reaction
  7. Polymorphic light eruption (reaction to sunlight on the skin)
  8. Pruritus (severe itching of the skin)
  9. Rash papular (redness with papule)
  10. Skin eruption

60+:

  1. Anaemia (lack of blood)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  4. Pain in extremity
  5. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  6. Vision blurred
  7. White blood cell count decreased

What are the existing conditions these people have? *

  1. Nasopharyngitis (inflammation of the nasopharynx): 4 people, 22.22%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 22.22%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 11.11%
  5. Ovarian Cancer (cancer of ovary): 2 people, 11.11%
  6. Neuropathy Peripheral (surface nerve damage): 2 people, 11.11%
  7. Birth Control: 2 people, 11.11%
  8. Insomnia (sleeplessness): 2 people, 11.11%
  9. High Blood Pressure: 2 people, 11.11%
  10. High Blood Cholesterol: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Malarone and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Malarone and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Malarone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Malarone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on atovaquone; proguanil hydrochloride and ibuprofen (the active ingredients of Malarone and Profen, respectively), and Malarone and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: